XML 30 R8.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities    
Net loss $ (124,433) $ (415,581)
Adjustments to reconcile net loss    
Depreciation and amortization 60,535 71,831
Original issue discount, debt premium and debt issuance cost amortization 5,411 15,261
Interest paid on BR Exar Facility 10,754  
Debt modification and extinguishment gain, net (17,534) (1,803)
Impairment of goodwill and other intangible assets   171,182
Impairment of operating lease right-of-use assets 1,942  
Credit loss expense 4,486 1,573
Deferred income tax provision (1,048) 147
Share-based compensation expense 115 970
Unrealized foreign currency gain (70) (1,288)
(Gain) loss on sale of assets (7,044) 707
Change in operating assets and liabilities    
Accounts receivable 22,729 77,650
Prepaid expenses and other current assets 5,523 (7,813)
Accounts payable and accrued liabilities 63,711 (520)
Related party payables (71) 945
Additions to outsource contract costs (539) (423)
Net cash provided by (used in) operating activities 3,556 (87,162)
Cash flows from investing activities    
Purchase of property, plant and equipment (8,075) (18,299)
Additions to patents   (15)
Additions to internally developed software (3,818) (3,650)
Proceeds from sale of assets 29,811 194
Net cash provided by (used in) investing activities 17,918 (21,770)
Cash flows from financing activities    
Cash received in exchange for the issuance of noncontrolling interest shares in XBP Europe 5,205  
Cash paid for equity issuance costs from at the market offerings (2,232) (9,482)
Dividend paid on Series B Preferred Stock   (2,532)
Payment for fractional shares on reverse stock split (31)  
Repurchases of Common Stock for retirement   (487)
Borrowings under factoring arrangement and Securitization Facility 88,396 123,353
Principal repayment on borrowings under factoring arrangement and Securitization Facility (92,536) (216,812)
Cash paid for withholding taxes on vested RSUs   (135)
Lease terminations   3
Cash paid for debt issuance costs (8,496) (7,125)
Principal payments on finance lease obligations (4,570) (5,523)
Repayments under revolving facility   (49,477)
Proceeds from issuance of July 2026 Notes   70,269
Borrowings from other loans 8,709 10,095
Cash paid for debt repurchases (11,858) (4,712)
Proceeds from Senior secured term loan 40,000  
Proceeds from Second Lien Note 31,500  
Repayment of BRCC term loan (48,529) (66,471)
Principal repayments on senior secured term loans and other loans (83,787) (30,717)
Net cash provided by (used in) financing activities 624 106,639
Effect of exchange rates on cash, restricted cash and cash equivalents (12) (700)
Net increase (decrease) in cash, restricted cash and cash equivalents 22,086 (2,993)
Cash, restricted cash, and cash equivalents    
Beginning of period 45,067 48,060
End of period 67,153 45,067
Supplemental cash flow data:    
Income tax payments, net of refunds received 5,494 5,790
Interest paid 111,835 98,602
Noncash investing and financing activities:    
Assets acquired through right-of-use arrangements 405 4,790
Issuance of April 2026 Notes in exchange of July 2026 Notes 764,800  
Issuance of April 2026 Notes in exchange of 2023 term loan 2,963  
Accrued PIK interest paid through issuance of PIK Notes 44,146  
Common Stock exchanged for Series B Preferred Stock   6
Accrued liability for true-up obligation settled through the issuance of July 2026 Notes   10,351
Accrued capital expenditures 2,261 1,851
BR EXAR    
Cash flows from financing activities    
Borrowings under revolving facility 42,539  
Repayments under revolving facility (42,546)  
Revolving Credit Facility BRCC Term Loan    
Cash flows from financing activities    
Borrowings under revolving facility 9,600 20,000
Private Placement    
Cash flows from financing activities    
Proceeds from issuance of Common Stock   55
At the Market Offering    
Cash flows from financing activities    
Proceeds from issuance of Common Stock 69,260 $ 276,337
XBP Europe's    
Adjustments to reconcile net loss    
Fair value adjustment for private warrants liability of XBP Europe $ 597